Performance of CT scan in predicting the feasibility of primary optimal cytoreduction in ovarian cancer

Liza Tasrin; Jesmin Sultana; Shamim Ara; Ayesha Siddika Purabi

doi:10.18203/2320-1770.ijrcog20260166

Authors

Liza Tasrin Department of Obstetrics and Gynaecology, Bangladesh Secretariat Clinic, Dhaka, Bangladesh
Jesmin Sultana Department of Gynaecological Oncology, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
Shamim Ara Department of Obstetrics and Gynaecology, Directorate General of Health Services (DGHS), Dhaka, Bangladesh
Ayesha Siddika Purabi Department of Obstetrics and Gynaecology, Dhaka Medical College Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20260166

Keywords:

Ovarian cancer, Cytoreductive surgery, CT scan, Predictive score, Debulking outcome

Abstract

Background: Ovarian cancer is frequently diagnosed at an advanced stage and optimal cytoreduction remains the most important prognostic factor for survival. Accurate preoperative assessment is essential to identify patients who are likely to benefit from primary debulking surgery. This study evaluated the diagnostic performance of CT scanning and a structured CT scoring system in predicting optimal cytoreduction among women with suspected ovarian cancer. This study aimed to assess the accuracy of preoperative CT findings and total CT score in determining the feasibility of optimal cytoreduction.

Methods: This prospective observational study was conducted at Gynecological Oncology Unit, Department of Obstetrics and Gynecology, Dhaka Medical College Hospital, Dhaka, Bangladesh, from July 2021 to June 2022. Fifty patients with suspected ovarian cancer underwent contrast-enhanced CT scanning before primary cytoreductive surgery. Five CT parameters were evaluated and assigned scores from 0 to 2, producing a total CT score ranging from 0 to 10. CT findings were compared with peroperative findings and histopathology. Diagnostic performance, associations between CT score and surgical outcome were analyzed using SPSS.

Results: Optimal cytoreduction was achieved in 70% of patients. CT showed high sensitivity for ascites, omental involvement, peritoneal thickening and lymph node metastasis. Increasing CT score correlated with a higher likelihood of suboptimal cytoreduction. A CT score ≥3 demonstrated a specificity of 100% and a significant association with suboptimal debulking.

Conclusions: Preoperative CT assessment, particularly total CT score, is a valuable tool for predicting optimal cytoreduction and guiding treatment decisions in ovarian cancer.

Metrics

Metrics Loading ...

References

Hoque ME, Karim S, Siddiqui MM, Ahmed T. Report on three cases of advance ovarian cancer upon Bangladeshi population: successful management with bevacizumab-based chemotherapy. Anwer Khan Modern Med Coll J. 2017;8(2):157-61. DOI: https://doi.org/10.3329/akmmcj.v8i2.33675

Devan SM, Pailoor J, Sthaneshwar P, Narayanan V. Pattern of tissue expression of CA-125 and HE4 in primary epithelial ovarian tumours and correlation with serum CA-125 levels. Asian Pac J Cancer Prev. 2013;14(8):4545-8. DOI: https://doi.org/10.7314/APJCP.2013.14.8.4545

Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363(10):943-53. DOI: https://doi.org/10.1056/NEJMoa0908806

Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment and outcome. J Reprod Med. 2013;58(12):469-76.

Herzog TJ, Alvarez RD, Secord A, Goff BA, Mannel RS, Monk BJ, et al. SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm. Gynecol oncol. 2014;135(1):3-7. DOI: https://doi.org/10.1016/j.ygyno.2014.08.004

Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer. 2004;101(2):346-52. DOI: https://doi.org/10.1002/cncr.20376

Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007;25(4):384-9. DOI: https://doi.org/10.1200/JCO.2006.07.7800

Chang SJ, Bristow RE, Chi DS, Cliby WA. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol. 2015;26(4):336-42. DOI: https://doi.org/10.3802/jgo.2015.26.4.336

Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—a prospective study. Gynecol Oncol. 2008;108(2):265-70. DOI: https://doi.org/10.1016/j.ygyno.2007.11.002

Naik R, Suchitra R, Naik B. Comparative study of pre-operative CT scan and per-operative findings in carcinoma ovary. Int J Reprod Contracept Obstet Gynecol. 2015;4(5):1367-73. DOI: https://doi.org/10.18203/2320-1770.ijrcog20150713

Borley J, Wilhelm‐Benartzi C, Yazbek J, Williamson R, Bharwani N, Stewart V, et al. Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer. BJOG. 2015;122(6):843-9. DOI: https://doi.org/10.1111/1471-0528.12992

Ferrandina G, Sallustio G, Fagotti A, Vizzielli G, Paglia A, Cucci E, et al. Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer. 2009;101(7):1066-73. DOI: https://doi.org/10.1038/sj.bjc.6605292

Gerestein CG, Eijkemans MJ, Bakker J, Elgersma OE, Van der Burg ME, Kooi GS, et al. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer. Anticancer Res. 2011;31(11):4043-9.

Mousavi AS, Mazhari MM, Guilani MM, Ghaemmaghami F, Behtash N, Akhavan S. Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?. World J Surg Oncol. 2010;8(1):11. DOI: https://doi.org/10.1186/1477-7819-8-11

Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol. 1993;11(1):166-72. DOI: https://doi.org/10.1200/JCO.1993.11.1.166

Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000;89(7):1532-40. DOI: https://doi.org/10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A

Glaser G, Torres M, Kim B, Aletti G, Weaver A, Mariani A, et al. The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer. Gynecol oncol. 2013;130(2):280-3. DOI: https://doi.org/10.1016/j.ygyno.2013.05.007

Meyer JI, Kennedy AW, Friedman R, Ayoub A, Zepp RC. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR. Am J roentgenol. 1995;165(4):875-8. DOI: https://doi.org/10.2214/ajr.165.4.7676985

Sahdev A. CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning. Cancer Imaging. 2016;16(1):19. DOI: https://doi.org/10.1186/s40644-016-0076-2